| 摘要 |
<p>A pharmaceutical composition comprising particles of nedocromil calcium having a mass median diameter of from 0.01 to 10 microns and a water content of from 6 to 12% w/w in admixture with coarser particles of a solid pharmaceutically acceptable carrier is useful inter alia in the inhalation treatment of reversible obstructive airways disease. The nedocromil calcium particles preferably have a mass median diameter in the range 2 to 6 microns, and a water content of between 8 and 12% w/w. The carrier is preferably crystalline lactose, and preferably has a mass median diameter of from 30 to 80 microns.</p> |
